Viscofan, S.A. Stock price

Equities

VIS

ES0184262212

Non-Paper Containers & Packaging

Delayed BME 12:35:12 2024-03-28 pm EDT 5-day change 1st Jan Change
58.9 EUR +0.17% Intraday chart for Viscofan, S.A. +2.08% +9.89%
Sales 2024 * 1.28B 1.38B Sales 2025 * 1.33B 1.44B Capitalization 2.71B 2.93B
Net income 2024 * 166M 179M Net income 2025 * 180M 194M EV / Sales 2024 * 2.2 x
Net Debt 2024 * 93.44M 101M Net Debt 2025 * 130M 140M EV / Sales 2025 * 2.13 x
P/E ratio 2024 *
16.6 x
P/E ratio 2025 *
15.3 x
Employees 5,332
Yield 2024 *
4.04%
Yield 2025 *
3.96%
Free-Float 79.72%
More Fundamentals * Assessed data
Dynamic Chart
Viscofan, S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Inmedical Therapeutcs announced that it has received ?0.8 million in funding from Viscofan, S.A., Gestión de Capital Riesgo del País Vasco, SGEIC, S.A. CI
Viscofan, S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Viscofan, S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Viscofan, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Cocoon Bioscience SL announced that it has received €15 million in funding from Cleon Capital Advisors SL, North South Ventures, Viscofan, S.A. and other investors CI
Viscofan, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Viscofan, S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
ODS Protein announced that it has received funding from Viscofan, S.A. CI
Viscofan, S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Viscofan, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Insekt Label Biotech S.L announced that it has received $4.69 million in funding from Clave Mayor SGEIC, S.A., Viscofan, S.A. CI
Viscofan, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Viscofan, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Viscofan, S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 CI
More news
1 day+0.17%
1 week+2.08%
Current month+13.05%
1 month+13.49%
3 months+9.28%
6 months+2.26%
Current year+9.89%
More quotes
1 week
57.50
Extreme 57.5
59.00
1 month
52.30
Extreme 52.3
59.50
Current year
51.70
Extreme 51.7
59.50
1 year
51.60
Extreme 51.6
68.25
3 years
48.92
Extreme 48.92
68.85
5 years
40.12
Extreme 40.12
68.85
10 years
36.84
Extreme 36.84
68.85
More quotes
Managers TitleAgeSince
Chief Executive Officer - 95-12-31
Director of Finance/CFO - 10-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - 99-01-27
Director/Board Member - 14-04-10
Chief Executive Officer - 95-12-31
More insiders
Date Price Change Volume
24-03-28 58.9 +0.17% 33,785
24-03-27 58.8 +0.68% 26,566
24-03-26 58.4 +1.21% 36,216
24-03-25 57.7 -0.35% 28,869
24-03-22 57.9 +0.35% 33,783

Delayed Quote BME, March 28, 2024 at 12:35 pm EDT

More quotes
Viscofan SA is a Spain-based company engaged in the packaging industry, mainly for meat products. The Company focuses on the manufacture and distribution of artificial castings, as well as plastic films that are used for separation of sliced food. Its products range includes cellulose, collagen, fibrous and plastic castings. In addition, it designs and produces packing machinery, as well as provides related spare parts. The Company also sells electric power, which is produced by cogeneration systems. The Company operates manufacturing plants and sales offices in Spain, Serbia, Czech Republic, Germany, Brazil, Mexico, Uruguay, China and the United States, among others. It controls a number of subsidiaries, such as Nanopack, Technology and Packaging SL, Naturin Viscofan GmbH and Viscofan Centroamerica Comercial SA.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
58.9 EUR
Average target price
70.55 EUR
Spread / Average Target
+19.78%
Consensus
  1. Stock
  2. Equities
  3. Stock Viscofan, S.A. - BME